Barclays

Institution

5% stake reports: 193
5% stake stocks: 99
Latest report: 26/09/08

5% stake reports

	Stock			Kind
09/08	QVC Group QVCG09/08	3.36%1,681,369 sh	−6.8pp	13G passiveAmendment
09/08	QVC Group QVCG09/08	10.21%5,106,642 sh	First report	13G passive
08/14	Rising Dragon Acquisition RDAC08/14	6.74%273,125 sh	+1.4pp	13G passiveAmendment
08/13	Reviva Pharmaceuticals Holdings RVPH08/13	0%20 sh	−6.0pp	13G passiveAmendment
08/13	Tavia Acquisition TAVI08/13	0.17%15,654 sh	−5.3pp	13G passiveAmendment
08/13	Range Capital Acquisition RANG08/13	0.04%7,410 sh	−7.0pp	13G passiveAmendment
08/13	Madison Square Garden Entertainment MSGE08/13	4.54%1,837,155 sh	−0.6pp	13G passiveAmendment
08/13	NewHold Investment Corp. III NHIC08/13	4.13%863,817 sh	−1.4pp	13G passiveAmendment
08/13	Zentalis Pharmaceuticals ZNTL08/13	3.17%2,263,328 sh	−2.1pp	13G passiveAmendment
08/13	Everspin Technologies MRAM08/13	1.89%444,629 sh	−3.1pp	13G passiveAmendment
08/13	Bel Fuse BELFA08/13	1.72%36,523 sh	−4.6pp	13G passiveAmendment
08/13	Axiom Intelligence Acquisition Corp 1 AXIN08/13	5.97%1,231,531 sh	+2.2pp	13G passive
08/13	Penumbra PEN08/13	5.95%2,342,118 sh	First report	13G passive
08/13	Roman DBDR Acquisition Corp. II DRDB08/13	5%1,150,688 sh	+2.0pp	13G passive
08/13	Launch Two Acquisition LPBB08/13	4.97%1,144,279 sh	−0.1pp	13G passiveAmendment
08/13	Lakeshore Acquisition III LCCC08/13	4.91%437,759 sh	−0.1pp	13G passiveAmendment
08/13	Oaktree Acquisition Corp. III Life Sciences OACC08/13	6.99%1,384,810 sh	+2.6pp	13G passive
08/13	CH4 Natural Solutions MTNE08/13	6.81%1,512,500 sh	First report	13G passive
08/13	Cartesian Therapeutics RNAC08/13	5.99%1,760,326 sh	First report	13G passive
08/13	Office Properties Income Trust OPI08/13	8.43%1,852,220 sh	First report	13G passive